Insulet (NSDQ:PODD) last month named Bret Christensen as its chief commercial officer to lead the company’s sales, marketing, customer care, market access and advocacy.
He most recently served as GM of Myriad Genetics’ preventive care business division.
He has also worked as VP of sales and marketing of the gynecologic surgical products unit at Hologic.
Get the full story at our sister site, Drug Delivery Business News.
The post Insulet brings on new chief commercial exec | Personnel Moves – June 5, 2017 appeared first on MassDevice.